Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference8 articles.
1. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin;Palou;Eur Urol,2012
2. Long-term cancer specific survival in patients with high-risk non–muscle-invasive bladder cancer and tumour progression: a systematic review;van den Bosch;Eur Urol,2011
3. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease specific survival: a prospective randomised clinical trial;Divrik;Eur Urol,2010
4. Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate;Stanislaus;World J Urol,2010
5. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non–muscle-invasive bladder cancer;Malmström;Eur Urol,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoplasms of the Urinary Bladder;Urologic Surgical Pathology;2020
2. Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review;European Urology;2018-06
3. Segunda resección transuretral y pronóstico del cáncer de vejiga no músculo-invasivo de alto grado en pacientes que no reciben bacilo de Calmette-Guérin;Actas Urológicas Españolas;2014-04
4. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Guérin;Actas Urológicas Españolas (English Edition);2014-04
5. Tratamiento del tumor vesical no músculo infiltrante frente al problema de disponibilidad de bacilo de Calmette-Guerin. Consenso de un panel de expertos españoles;Actas Urológicas Españolas;2013-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3